Skip to main content

Spineway wins new approvals in Vietnam and registers initial orders

Written by Customer Service on . Posted in Public Companies.

Press release        

Ecully, December 18, 2024 – 6 p.m.

Spineway wins new approvals in Vietnam
and registers initial orders

The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that it has obtained approvals for its ACIFBOX, VEOS, KAPHORN and TWIN PEAKS ranges in Vietnam. Following this approval, initial orders have been placed, confirming the growing interest in Spineway products in the region.

These approvals will enable Spineway to meet the needs of Vietnamese surgeons by offering high-performance solutions adapted to local requirements. They will also allow the Group to strengthen its presence and market share in this country, where its ESP prostheses have already been on the market for several years.

                            

To help drive this momentum, the Group lent its support to its local distributors during the first product presentations at the 23rd Vietnam Neurosurgery Conference (VNC 2024), held in Ho Chi Minh City on December 6 and 7. This event brought together the major players in the field of spine surgery in Southeast Asia and provided an ideal platform to showcase Spineway’s innovations while strengthening ties with healthcare professionals in Asia.

Spineway continues to consolidate its presence in Asia, demonstrating its ability to meet the expectations of international surgeons. These advances illustrate and confirm the Group’s strategy to position itself as a benchmark in spine surgery.

Next event:
January 22, 2025 – Full-year 2024 revenue

SPINEWAY IS ELIGIBLE FOR PEA-SME (EQUITY SAVINGS PLANS FOR SMES)
Find out all about Spineway at www.spineway.com

This press release has been prepared in both English and French. In case of discrepancies, the French version shall prevail.

Spineway designs, manufactures and markets innovative implants and surgical instruments for treating severe disorders of the spinal column.
Spineway has an international network of independent distributors and derives more than 70% of its revenue from exports.
ISIN: FR001400BVK2 – ALSPW        

Contacts:

SPINEWAY

Shareholder-services line

Available Tuesday through Thursday

+33 (0)806 706 060

 

AELIUM

Investor relations

Solène Kennis

spineway@aelium.fr

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.